Navigation Links
Reliv’s LunaRich X Named Finalist for 2013 American Business Awards

Chesterfield, MO (PRWEB) May 09, 2013

Reliv International, Inc.’s newest product, LunaRich X™, today was named a finalist in the New Product or Service of the Year – Consumer Products category in the 2013 American Business Awards, also known as the Stevie® Awards.

The American Business Awards are the nation’s premier business awards program. All organizations operating in the U.S.A. are eligible to submit nominations – public and private, for-profit and non-profit, large and small.

The Science of LunaRich X

LunaRich X is the most pure, concentrated form of lunasin ever produced. Lunasin is a naturally occurring peptide scientists have identified as responsible for many of soy’s documented health benefits, including cholesterol reduction and general cellular health. Learn more about the benefits of lunasin.

Just one 125mg capsule of LunaRich X delivers the same amount of bioactive lunasin found in 25 grams of high-quality soy protein, the daily amount identified by the Food and Drug Administration to help reduce the risk of heart disease.

LunaRich X marks the culmination of an extensive research and development process that began with the discovery of the lunasin peptide by research scientist Dr. Alfredo Galvez at UC Berkley in 1996. Lunasin is now one of the most heavily researched and scientifically supported nutritional compounds available today, with more than 50 published papers from more than 25 research institutions.

Lunasin and Epigenetics

Lunasin is the first bioactive compound identified to affect gene expression and promote optimal health at the epigenetic level. The epigenome, which literally means “beyond the genome,” is a higher level of complexity within the cell. Learn more about lunasin and epigenetics.

In the epigenome, lunasin performs two functions:

  •     prevents enzymes in histones from turning on unhealthy gene expression
  •     activates enzymes in histones that promote healthy gene expression

“No other company is advancing the nutritional possibilities of the emerging field of epigenetics like Reliv, and LunaRich X is the culmination of that work,” Galvez said. “We are in the middle of a revolution in nutrition and we are all witnesses.”

About Reliv International, Inc.
Reliv International, based in Chesterfield, Mo., produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition, weight loss, athletic performance, digestive health, women's health, anti-aging and healthy energy. Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, the peptide behind many of soy’s health benefits. The company sells its products through an international network marketing system of independent distributors in 16 countries. Learn more about Reliv at, or on Facebook, Twitter or YouTube.

Reliv products previously named Stevie finalists in include healthy energy shot 24K™ (also honored as winner of the ABA’s People’s Choice Award) and Reliv’s r skincare line.

About the Stevie Awards
Stevie Awards are conferred in four programs: The American Business Awards, The International Business Awards, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service. A fifth program, the Asia-Pacific Stevie Awards, will debut this year. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about the Stevie Awards at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Indigo Biosystems Named ‘Best Place to Work’ in Indiana
2. University of Rochester named Center for AIDS Research by the National Institutes of Health
3. Physician Patient Safety Leader Named President of National Patient Safety Foundation
4. VisionWare Named as Supplier on Ground-Breaking G-Cloud Framework
5. U-Ms Yamashita named Howard Hughes Medical Institute investigator
6. Perspectives Ltd Named as One of the Best Places to Work in Illinois 2013
7. Ottawa researcher named 2013 Champion of Genetics
8. Dr. Anthony Iselborn Named 2013 Sports Chiropractor of The Year by the American Chiropractic Board of Sports Physicians
9. Cornerstone Hospice Named as 2013 Hospice Honors Recipient
10. It Works! Global Named Top Company for Growth and Momentum
11. De Caro and Kaplen Brain Injury Attorney Michael V. Kaplen Named Fellow of the Litigation Counsel of America
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... Water For Empowerment ™ attracts volunteers together who want to combine talents ... women as key stakeholders in the process. The non-profit launched its first major ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in ... on several models of traditional and far-infrared saunas. , For traditional saunas, ... the most traditional Finnish sauna wood, and Finnleo uses only European Grade A Nordic ...
(Date:11/25/2015)... Cokato, MN (PRWEB) , ... November 25, 2015 ... ... manufacturer, launched offering factory direct sauna parts and accessories. , Sauna accessories ... representative of the bather’s style and personality. From basic styles for the purist ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, ... Union (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, civil ... for the opening of the 5th African Network for Drugs and Diagnostics Innovation, ...
(Date:11/25/2015)... Friendswood, TX (PRWEB) , ... November 25, 2015 , ... ... through the companies’ “ Two Organizations, One Beat ” campaign. The partnership between the ... its services to aid in MAP International’s cause. , MAP International was founded in ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... of the "2016 Future Horizons and Growth ... Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> --> ... of the Italian therapeutic drug monitoring market, including ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... MINNEAPOLIS , Nov. 25, 2015  ARKRAY ... care products, continues to provide evidence demonstrating the accuracy ... the World Congress on Insulin Resistance, Diabetes and Cardiovascular ... showed that both the Company,s GLUCOCARD ® 01 ... met high accuracy requirements. The ability to accurately measure ...
Breaking Medicine Technology: